Peri wearable for perimenopause tracking debuts at CES 2026

Peri, a wearable designed to monitor perimenopausal symptoms, is on display at CES 2026 and is available to preorder for $449. The nonintrusive device, which Peri says attaches near the stomach, looks similar in size to a continuous glucose monitor and is packaged with four sensors: PPG for blood flow, an accelerometer, EDA for measuring skin electricity, and a temperature sensor.

Peri says these sensors capture biomarkers such as body temperature, sleep and cycle information and that its custom algorithm uses a mix of data metrics to detect and monitor symptoms including hot flashes, night sweats, anxiety and sleep-pattern changes. The company says the device records biomarkers for around seven to 10 days before requiring a recharge.

Peri logs symptoms in the context of a user’s menstrual cycle and can document hormone-therapy treatment journeys; the app displays sleep timing, an anxiety score, activity level, cycle information, daily/weekly/longitudinal insights and a journal feature. IdentifyHer says the product was born from a gap in symptom data caused by poor diagnostics and limited clinician training.

"Perimenopause is treated like a mystery or an inevitability that women simply have to 'power through.' We reject this.

Key Topics

Tech, Peri, Identifyher, Perimenopause, Biosensor, Hormone Therapy